Godavari Biorefineries Limited is one of the biggest formulating ethanol chemicals manufacturing firms in India with the integrated biorefineries having ethanol formulation capacity from 30th June, 2024 at 570 KLPD.
Following these values of continuous improvement, the company has transformed into one of the largest ethanol producers in India in terms of volume as of 31 March 2024, where major production milestones have been realized. Thus, with reference to the installed capacity, Godavari Biorefineries was identified as the biggest MPO manufacturer by consumption up to March 31, 2024.
It is one of the two companies in the world that synthesize natural 1,3 butylene glycol and is one of the only firms that produces ethyl acetate in India. Besides, it has set up an EVE manufacturing site with a 100% bio-based facility in India as of the same date.
IPO Details
- Open Date: January 20, 2025
- Close Date: January 22, 2025
- Allotment Date: January 23, 2025
- Listing Date: January 27, 2025
- Price Band: ₹250 to ₹263 per equity share
- Market Lot: 400 shares (minimum investment of ₹1,05,200)
- Total Issue Size: ₹169.37 crore
- Fresh Issue: ₹84.69 crore
- Offer for Sale: ₹84.69 crore (32.20 lakh shares)
The IPO will be conducted through a book-built issue format, with GYR Capital Advisors Private Limited serving as the lead manager and Link Intime India Private Ltd acting as the registrar.
As is evident from the above financial analysis, the Godavari Biorefineries company has a broad portfolio of products, which are bio-based chemicals, sugar, different types of ethanol, and power.
All of these products are used in various industries for instance the food and beverages processing and packaging industries, the pharmaceutical industries; the industries in production of flavors and fragrances, power and fuel industries; the personal industries as well as cosmetics among others.
The Sameerwadi Manufacturing Facility of the corporation, having a crushing capacity of 18,000 TCD as of 30 June 2024, has put the company in the league of the first fifteen largest sugar complexes in India. However, environmental approvals have been granted to the firm to increase the competence of crushing to 25000 TCD.
This company has had an opportunity to supply its products to clients in more than twenty countries, including Australia, China, Germany, France, Italy, Japan, Kenya, Netherlands, Singapore, the US, the UK, and UAE, among others, in the United States of America.
Investment Considerations
Investors considering participation in the CapitalNumbers Infotech IPO should evaluate several factors:
- Growth Potential: The increasing demand for IT services and digital solutions positions CapitalNumbers well within a rapidly expanding market.
- Financial Stability: The company’s consistent revenue growth and rising profits indicate strong operational health.
- Use of Proceeds: Funds raised through the IPO will be utilized for technological advancements, business development initiatives, and general corporate purposes.